CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,456 | -10.8% | 12,578 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $24,055 | +10.4% | 12,586 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $21,786 | -2.5% | 12,586 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $22,337 | -23.0% | 12,623 | -0.1% | 0.00% | -40.0% |
Q3 2022 | $29,000 | +3.6% | 12,636 | 0.0% | 0.01% | +25.0% |
Q2 2022 | $28,000 | -44.0% | 12,636 | -2.6% | 0.00% | -42.9% |
Q1 2022 | $50,000 | – | 12,978 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |